Sign in
Active, not recruitingNo phase

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Key facts

Who runs it
Vejle Hospital
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
20 people enrolled
Started
15 Nov 2024
Expected to end
Dec 2026
Type of study
Observational
Record updated
21 July 2026

Who can take part

Age
5 years to 14 years
Sex
Women and men

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Children treated with orthokeratology lenses
  • Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation
  • Treatment and follow-up duration ≥ 6 months

Who cannot take part

  • Active eye infection
  • Current use of eye drops
  • Objective signs of dry eyes on slit-lamp examination

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future.

Read full original descriptionShow less

The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control.

Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control. The ProMOC Study
Record updated
21 July 2026